Literature DB >> 19331837

The current and continuing important role of ventilation-perfusion scintigraphy in evaluating patients with suspected pulmonary embolism.

Leonard M Freeman1, Evan G Stein, Seymour Sprayregen, Murthy Chamarthy, Linda B Haramati.   

Abstract

After the publication of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) study in 1990, there was considerable controversy concerning the ventilation-perfusion (V/Q) study in regard to its low sensitivity and high number of nondiagnostic examinations when used in patients with suspected pulmonary embolism (PE). Many lessons have been learned from the PIOPED database that have greatly improved our interpretive skills in the 2 decades since the study was performed. One of the key problems negatively impacting interpretation was the predominantly inpatient population that was studied. Inpatients generally are sicker patients with abnormal chest x-rays. This factor significantly degrades V/Q interpretation. A normal chest x-ray greatly facilitates accurate interpretation of the lung scan. The emergence of computed tomography angiography (CTA) in the early to mid-1990s provided a superb new means of imaging patients with suspected PE. As this technology became more sophisticated with multidetector units, it became the procedure of choice in the great majority of medical centers. CT scanners located in or proximal to many emergency departments as well as its 24/7 availability supported this preference. Within the past 2 to 3 years, the publication of the PIOPED II study as well as some other prospective and retrospective studies have confirmed similar diagnostic accuracy for CTA and V/Q studies. Additionally, there have been several recent publications cautioning physicians about the large radiation dose associated with CTA, particularly to the female breast. Considering the great benefits of both techniques as well as their limitations, it is prudent for both clinicians and imaging physicians to develop an appropriate approach to studying patients with suspected PE. Considerations such as objective clinical assessment, D-dimer assay and the chest x-ray appearance all play significant roles in this decision-making process.

Entities:  

Mesh:

Year:  2008        PMID: 19331837     DOI: 10.1053/j.semnuclmed.2008.07.001

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  6 in total

1.  Ventilatory impairment detection based on distribution of respiratory-induced changes in pixel values in dynamic chest radiography: a feasibility study.

Authors:  Rie Tanaka; Shigeru Sanada; Masaki Fujimura; Masahide Yasui; Shiro Tsuji; Norio Hayashi; Hiroyuki Okamoto; Yuko Nanbu; Osamu Matsui
Journal:  Int J Comput Assist Radiol Surg       Date:  2010-06-13       Impact factor: 2.924

Review 2.  V/Q scintigraphy: alive, well and equal to the challenge of CT angiography.

Authors:  Leonard M Freeman; Linda B Haramati
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 3.  Imaging of suspected pulmonary embolism and deep venous thrombosis in obese patients.

Authors:  Vincent Cascio; Man Hon; Linda B Haramati; Animesh Gour; Peter Spiegler; Sanjeev Bhalla; Douglas S Katz
Journal:  Br J Radiol       Date:  2018-06-27       Impact factor: 3.039

4.  Hyperpolarized Xe MR imaging of alveolar gas uptake in humans.

Authors:  Zackary I Cleveland; Gary P Cofer; Gregory Metz; Denise Beaver; John Nouls; S Sivaram Kaushik; Monica Kraft; Jan Wolber; Kevin T Kelly; H Page McAdams; Bastiaan Driehuys
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

5.  Radiation dose from medical imaging: a primer for emergency physicians.

Authors:  Jesse G A Jones; Christopher N Mills; Monique A Mogensen; Christoph I Lee
Journal:  West J Emerg Med       Date:  2012-05

6.  Geriatric chest imaging: when and how to image the elderly lung, age-related changes, and common pathologies.

Authors:  J Gossner; R Nau
Journal:  Radiol Res Pract       Date:  2013-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.